Rajan P Kulkarni

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Basal Cell Carcinoma

Top Venues

Life (Basel, Switzerland)

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zachary R Garrison, Terri Clister, Eric Bleem, Elizabeth G Berry, Rajan P Kulkarni
Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers. Cancers 16 (5) (2024)
Terri Clister, Rosalyn M Fey, Zachary R Garrison, Cristian D Valenzuela, Anna Bar, Justin J Leitenberger, Rajan P Kulkarni
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets. Cells 13 (3) (2024)
Terri Clister, Rosalyn M Fey, Zachary R Garrison, Cristian D Valenzuela, Anna Bar, Justin J Leitenberger, Rajan P Kulkarni
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets. Cells 13 (3) (2024)
Rosalyn M Fey, Rebecca A Nichols, Thuy T Tran, Arthur A Vandenbark, Rajan P Kulkarni
MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy. Cancers 16 (9) (2024)
Terri Clister, Rosalyn M Fey, Zachary R Garrison, Cristian D Valenzuela, Anna Bar, Justin J Leitenberger, Rajan P Kulkarni
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets. Cells 13 (3) (2024)
Rosalyn M Fey, Rebecca A Nichols, Thuy T Tran, Arthur A Vandenbark, Rajan P Kulkarni
MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy. Cancers 16 (9) (2024)
Terri Clister, Rosalyn M Fey, Zachary R Garrison, Cristian D Valenzuela, Anna Bar, Justin J Leitenberger, Rajan P Kulkarni
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets. Cells 13 (3) (2024)
Zachary R Garrison, Terri Clister, Eric Bleem, Elizabeth G Berry, Rajan P Kulkarni
Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers. Cancers 16 (5) (2024)
Terri Clister, Rosalyn M Fey, Zachary R Garrison, Cristian D Valenzuela, Anna Bar, Justin J Leitenberger, Rajan P Kulkarni
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets. Cells 13 (3) (2024)
Rosalyn M Fey, Rebecca A Nichols, Thuy T Tran, Arthur A Vandenbark, Rajan P Kulkarni
MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy. Cancers 16 (9) (2024)
Terri Clister, Rosalyn M Fey, Zachary R Garrison, Cristian D Valenzuela, Anna Bar, Justin J Leitenberger, Rajan P Kulkarni
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets. Cells 13 (3) (2024)
Zachary R Garrison, Connor M Hall, Rosalyn M Fey, Terri Clister, Nabeela Khan, Rebecca Nichols, Rajan P Kulkarni
Advances in Early Detection of Melanoma and the Future of At-Home Testing. Life (Basel, Switzerland) 13 (4) (2023)
Zachary R Garrison, Connor M Hall, Rosalyn M Fey, Terri Clister, Nabeela Khan, Rebecca Nichols, Rajan P Kulkarni
Advances in Early Detection of Melanoma and the Future of At-Home Testing. Life (Basel, Switzerland) 13 (4) (2023)
Zachary R Garrison, Connor M Hall, Rosalyn M Fey, Terri Clister, Nabeela Khan, Rebecca Nichols, Rajan P Kulkarni
Advances in Early Detection of Melanoma and the Future of At-Home Testing. Life (Basel, Switzerland) 13 (4) (2023)
Zachary R Garrison, Connor M Hall, Rosalyn M Fey, Terri Clister, Nabeela Khan, Rebecca Nichols, Rajan P Kulkarni
Advances in Early Detection of Melanoma and the Future of At-Home Testing. Life (Basel, Switzerland) 13 (4) (2023)
Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, Diwakar Davar, Geoffrey Thomas Gibney, Omid Hamid, Tina J Hieken, Benjamin Izar, Douglas B Johnson, Rajan P Kulkarni, Jason John Luke, Tara C Mitchell, Meghan J Mooradian, Krista M Rubin, April Ks Salama, Keisuke Shirai, Janis M Taube, Hussein A Tawbi, J Keith Tolley, Caressa Valdueza, Sarah A Weiss, Michael K Wong, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. Journal for immunotherapy of cancer 11 (10) (2023)
Reilly G Fankhauser, Matthew Chang, Zachary R Garrison, Rachel Berryman, Olivia M Lucero, Allison Fuiten, Nicholas DePatie, Hilary Seifert, Rajan P Kulkarni
Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells. Cancers 14 (19) (2022)
Zachary R Garrison, Matthew Chang, Noah Hornick, Wesley Y Yu, Jeffrey B Cheng, Rajan P Kulkarni
A Novel Potential Role for Monocytes Revealed by Single Cell Analysis of Immunotherapy Induced Immune Related Adverse Events. Cancers 14 (21) (2022)
Riyad N H Seervai, Avilasha Sinha, Rajan P Kulkarni
Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies. Clinical and experimental dermatology 47 (11) (2022)
Allison M Fuiten, Reilly G Fankhauser, Darren J Smit, Mitchell S Stark, Trevor F Enright, Mary A Wood, Nicholas A DePatie, Karla Pivik, Richard A Sturm, Elizabeth G Berry, Rajan P Kulkarni
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa. Pigment cell & melanoma research 34 (6) (2021)
Manjima Dhar, Jessica Wong, James Che, Melissa Matsumoto, Tristan Grogan, David Elashoff, Edward B Garon, Jonathan W Goldman, Elodie Sollier Christen, Dino Di Carlo, Rajan P Kulkarni
Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer. Scientific reports 8 (1) (2018)
John Shen, Jason Chang, Melody Mendenhall, Grace Cherry, Jonathan W Goldman, Rajan P Kulkarni
Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management. Therapeutic advances in medical oncology 10 (2018)